Sponsor or institution

Clinical trials and research at Electra Therapeutics Inc.

• 2Clinical trials
• 7Countries

All recruiting trials (2)

• ELA026 for adults with relapsed or refractory T-cell and NK-cell cancers

  This Phase 1 trial will test whether ELA026 can help adults with relapsed or refractory T/NK cell cancers who have already received prior therapies.

  Recruiting at 6 sites Phase 1 Electra Therapeutics Inc. · New Haven, Connecticut and 5 other locations · NCT07465835

• ELA026 treatment for secondary hemophagocytic lymphohistiocytosis (sHLH).

  This study will try ELA026, a monoclonal antibody, in children and adults with secondary HLH to see if it reduces the disease-driving immune activation and improves clinical outcomes.

  Recruiting at 32 sites Phase 2/3 Electra Therapeutics Inc. · Birmingham, Alabama and 41 other locations · NCT05416307

Quick answers

How many clinical trials run by Electra Therapeutics Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (2 trials), Austria (1 trial), Germany (1 trial), Italy (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →